PDS Biotechnology Corp (PDSB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

25B VREELAND ROAD FLORHAM PARK, NJ 07932

Edge Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company discovers, develops, and seek to commercialize hospital-based therapies for the management of acute, life-threatening neurological conditions. Edge Therapeutics serves customers worldwide.

Data as of 2021-05-08 11:42:04 -0400
Market Cap107.827 Million Shares Outstanding22.278 Million Avg 30-day Volume555.828 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.54 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.94283 52-week High/Low7.3 / 0.8202 Next Earnings Date2021-05-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PDSB instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 30 30 0.0% 9 (0.54%) 8 (0.5%) 12.5%
13F shares: 3.145 Million 3.295 Million -4.54% 1.361 Million 1.712 Million -20.55%
% Ownership 14.1289 14.8015 -4.54% 6.112 7.6925 -20.55%
New Positions: 7 10 -30.0% 2 3 -33.33%
Increased Positions 8 7 14.29% 2 2 0.0%
Closed Positions 7 6 16.67% 1 1 0.0%
Reduced Positions 2 1 100.0% 1
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PDSB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PDSB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VAN VOORHEES SETH CHIEF FINANCIAL OFFICER

0 2021-01-04 2

WOOD LAUREN CHIEF MEDICAL OFFICER

0 2020-12-08 2

CONN GREGORY CHIEF SCIENTIFIC OFFICER

0 2020-12-08 2

BEDU-ADDO FRANK PRESIDENT/CEO

0 2020-12-08 2

KING MICHAEL N. INTERIM CFO

0 2020-12-08 2

BRAWLEY OTIS W

0 2020-11-03 2

BLOOMQUIST DELYLE W

0 2020-06-23 1

SYKES RICHARD

0 2020-06-23 1

FREITAG GREGORY GENE

0 2020-06-23 1

GLOVER STEVE C

0 2020-06-23 1

ALI-JACKSON KAMIL

0 2020-06-23 1

ILIEV ILIAN

0 2020-06-23 1

TROCHIMIUK JANETTA PRINCIPAL ACCOUNTING OFFICER

0 2020-03-23 0

SAIK ANDREW CHIEF FINANCIAL OFFICER

42,549 2020-02-14 0

LOUGHLIN JAMES J

  • Director
0 2019-06-28 0

MIDDLEKAUFF W BRADFORD SENIOR VP, GC AND SECRETARY

  • Officer
73,770 2019-03-18 0

LEUTHNER BRIAN A PRESIDENT AND CEO

  • Officer
  • Director
633,384 2019-03-15 0

BLECH ISAAC

  • Director
10,000 2019-03-15 0

BARER SOL J

  • Director
678,075 2019-03-15 0

MACDONALD R. LOCH

  • Director
587,730 2019-03-15 0

SPIEGEL ROBERT J.

  • Director
48,661 2019-03-15 0

RATCLIFFE LIAM

  • Director
2,354,868 2019-03-15 0

CRANE ROSEMARY A

  • Director
10,000 2019-03-15 0

WYANT ALYSSA SVP REGULATORY AFFAIRS

  • Officer
10,710 2018-08-15 0

MARCHIO ALBERT N II CHIEF ACCOUNTING & ADM OFFICER

  • Officer
0 2018-08-14 0

FALECK HERBERT J CHIEF MEDICAL OFFICER

  • Officer
0 2018-08-14 0

CONTI KURT G

  • Director
1,113,961 2018-03-23 0

BRENNAN DANIEL CHIEF OPERATING OFFICER

  • Officer
0 2018-03-01 0

HEALY JAMES

  • Director
0 2017-06-20 0

YAMAN ALPASLAN V.P., TECHNICAL OPS. & MFG.

  • Officer
0 2017-03-13 0

EINHORN ANDREW J. CHIEF FINANCIAL OFFICER

  • Officer
126,815 2017-03-01 0

RATCLIFFE LIAM

NEW LEAF VENTURE PARTNERS, L.L.C.

  • Director
0 2016-06-21 0

RATCLIFFE LIAM

NEW LEAF VENTURES III, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURE PARTNERS, L.L.C.

  • Director
1,172,434 2016-06-21 0

VAISH RENU V.P., GLOBAL REG. AFFAIRS

  • Officer
5,350 2016-06-16 0

HOVE ANDERS D

  • Director
2,068,582 2015-10-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 22:15:03 UTC -6.5627 6.6127 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 21:45:03 UTC -6.5627 6.6127 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 21:15:03 UTC -6.5627 6.6127 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 20:45:03 UTC -6.5479 6.5979 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 20:15:04 UTC -6.5479 6.5979 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 19:45:02 UTC -6.5479 6.5979 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 19:15:03 UTC -6.5479 6.5979 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 18:45:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 18:15:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 17:45:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 17:15:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 16:45:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 16:15:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 15:45:03 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 15:15:02 UTC -6.4241 6.4741 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 14:45:04 UTC -6.5896 6.6396 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 14:15:03 UTC -6.5896 6.6396 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 13:45:03 UTC -6.5896 6.6396 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 13:15:03 UTC -6.5896 6.6396 350000
PDS BIOTECHNOLOGY CORP PDSB 2021-05-14 12:45:03 UTC -6.5896 6.6396 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments